BUSINESS
Zydus Cadila files NDA for Saroglitazar Magnesium
If the latest NDA is approved, Saroglitazar Mg could become the first medicine indicated for the treatment of Non-alcoholic Steatohepatitis (NASH).
BUSINESS
Here is why the govt advisory on oxytocin is drawing flak from IMA
Oxytocin is a hormonal drug used to induce labour, controls postpartum bleeding and stimulates lactation or milk production.
BUSINESS
Eris Lifesciences buys vildagliptin brand Zomelis from Novartis for $13 million
Eris added that it will start selling the product in the Indian market from December 10 onwards.
BUSINESS
USFDA's new draft guidelines on insulin products to help biosimilar makers like Biocon
Once insulins are regulated as biologics or biosimilars, it will become possible for drug companies to seek interchangeable designations for their products.
BUSINESS
Piramal Pharma Solutions partners with Norway-based BerGenBio to develop blood cancer drug
Bemcentinib is used for the treatment of elderly patients with relapsed Acute Myeloid Leukemia.
BUSINESS
Siddharth Mittal replaces Arun Chandavarkar as Biocon CEO and Jt MD
Mittal has been serving as Biocon’s chief financial officer (CFO) since August 2014.
BUSINESS
Will sale of assets be enough to resolve Wockhardt's problems?
Moneycontrol on November 29 reported on Cipla emerging as a major contender for some of these divisions of Wockhardt that are up for sale.
BUSINESS
Biocon and Mylan launch Trastuzumab biosimilar Ogivri in USA
Ogivri was the first biosimilar of Herceptin to be approved by USFDA two years ago, for the treatment of HER2-overexpressing breast cancer and metastatic stomach cancer.
BUSINESS
Pharma wrap: A closer look at drug price controls and shortages
Pharmaceutical companies have sought discontinuation of critical drugs, citing lack of financial viability, as the prices for raw materials have shot up, and their inability to pass on the price to consumers
BUSINESS
Suven's Alzheimer's molecule fails to meet primary end point in phase-2 trial
SUVN-502's clinical trial data assumed significance as no new Alzheimer's drug has been approved since Forest Labs' Namenda in 2003
BUSINESS
German glass maker Schott to double India capacity, to invest 26 million euros targeting pharma industry
The company is forecasting a rapid growth trend for high quality glass material in the pharma industry, and has thus committed additional investments of 26 million euros for yet another tank facility in 2020.
BUSINESS
Unable to buy Limcee Vitamin-C tablets from medical stores? Blame it on China
When Kothari prodded his chemist, he told him that there is shortage of Rs 15 - Limcee pack in the market, and what he is offering is the reformulated version of Limcee, called Limcee Plus.
BUSINESS
Rise in fire insurance premium hits bulk drugmakers hard
Insurance companies have more than doubled fire insurance premium due to a rise in claims
BUSINESS
Stent maker SMT acquires controlling stake in Brazil-based Zarek
The drug-eluting stents (DES) market is expected to be over $100 million by 2020.
BUSINESS
Raining USFDA warning letters to Indian drug sites point to intensified regulatory risk
Around 18 pharma companies had received USFDA warning letters for their Indian plants in 2019 alone, these were more than half of the all the warning letters issued by the regulatory agency.
BUSINESS
Pharma wrap: J&J in news again Australian court rules against company over pelvic mesh lawsuit
An Australian Federal Court in Sydney found that J&J subsidiary Ethicon had sold the devices without warning women about the potential risks.
BUSINESS
Bengaluru-based Clinikk helps gig-economy workers get health coverage
Clinikk ties up with gig economy companies like OLA, Uber, Porter, Swiggy, among others to provide health coverage to their partners.
BUSINESS
Fate of Amaravati hangs in the balance as Jagan Reddy govt has different priorities
The YS Jagan Mohan Reddy-led government has decided to scrap a grand plan to build Amaravati Capital City Start-up Area project with the help of a Singapore Consortium.
BUSINESS
Roche gets DCGI nod to sell drug for small cell lung cancer
"Atezolizumab is the first cancer immunotherapy to receive an approval in India for the first line treatment of extensive-stage small cell lung cancer (ES-SCLC) when given in combination with chemotherapy," Roche India said.
BUSINESS
Cadila Healthcare heading for tough waters due to lack of big approvals in US, Moraiya warning letter
Shares of Ahmedabad-based drug maker had dropped 30 percent in 2019 on BSE, compared to 5.4 percent decline of S&P BSE Healthcare index in the same period.
BUSINESS
Piramal partners with Gates Foundation to improve health in India's tribal districts
The new collaborative will focus on improving health and nutrition in high-burden and tribal districts, in support of the Government of India's work to achieve Sustainable Development Goal (SDG) 3 by 2030.
BUSINESS
Pharma sector Q2 review: Domestic sales save the day for Indian drugmakers
Most drug makers said that they are committed for investing in domestic formulation business, both organically and through acquisitions.
BUSINESS
Online medical supplies platform Medikabazaar raises Rs 112 cr in Series B funding
The funding was led by healthcare-centric venture capital fund HealthQuad, Belgium-based diversified group Ackermans & van Haaren, investment firm Rebright Partners and Japan's Toppan Printing Co Limited, which is also making its maiden startup investment in India.
BUSINESS
Fortis to explore legal recourse after SC issues contempt notice in Singh bros case
The Supreme Court had earlier withheld an open offer by IHH after Japanese drug maker Daiichi had filed an affidavit on January 15 to stall transfer of funds from Fortis to Religare Health Trust
